ZELBORAF for Metastatic malignant melanoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 130 adverse event reports in the FDA FAERS database where ZELBORAF was used for Metastatic malignant melanoma.
Most Reported Side Effects for ZELBORAF
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Disease progression | 62 | 17.3% | 29 | 4 |
| Death | 49 | 13.7% | 49 | 4 |
| Rash | 45 | 12.6% | 4 | 10 |
| Arthralgia | 29 | 8.1% | 2 | 9 |
| Fatigue | 17 | 4.8% | 3 | 8 |
| Nausea | 16 | 4.5% | 3 | 10 |
| Asthenia | 14 | 3.9% | 2 | 4 |
| Dysphagia | 14 | 3.9% | 1 | 4 |
| Erythema | 14 | 3.9% | 4 | 2 |
| Photosensitivity reaction | 14 | 3.9% | 3 | 4 |
| Pyrexia | 13 | 3.6% | 1 | 6 |
| Diarrhoea | 12 | 3.4% | 4 | 6 |
| Pain in extremity | 12 | 3.4% | 1 | 5 |
| Drug ineffective | 11 | 3.1% | 6 | 3 |
| Malignant neoplasm progression | 11 | 3.1% | 7 | 2 |
Other Indications for ZELBORAF
Other Drugs Used for Metastatic malignant melanoma
NIVOLUMAB (4,628)
IPILIMUMAB (4,430)
DABRAFENIB (3,885)
PEMBROLIZUMAB (2,742)
TRAMETINIB DIMETHYL SULFOXIDE (2,031)
VEMURAFENIB (1,848)
TRAMETINIB (1,604)
COBIMETINIB (898)
ENCORAFENIB (865)
BINIMETINIB (841)